Medtronic plc (MDT)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 80.89 |
| Open | 81.44 |
| Bid | 80.47 x 1000 |
| Ask | 81.46 x 1100 |
| Day's range | 80.13 - 81.73 |
| 52-week range | 68.84 - 91.00 |
| Volume | |
| Avg. volume | 6,299,409 |
| Market cap | 107.447B |
| Beta (5Y monthly) | 0.78 |
| PE ratio (TTM) | 25.69 |
| EPS (TTM) | 3.15 |
| Earnings date | 23 May 2024 |
| Forward dividend & yield | 2.76 (3.41%) |
| Ex-dividend date | 21 Mar 2024 |
| 1y target est | 94.00 |
Simply Wall St.Shareholders in Medtronic (NYSE:MDT) are in the red if they invested three years ago
As an investor its worth striving to ensure your overall portfolio beats the market average. But if you try your hand...
ZacksMedtronic (MDT) Rises Higher Than Market: Key Facts
Medtronic (MDT) closed at $80.86 in the latest trading session, marking a +1.4% move from the prior day.
PR NewswireMedtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulator
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain. Inceptiv is the first Medtronic SCS device to offer a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time, keeping therapy in harmony with the motions of daily life.
© 2024 Yahoo. All rights reserved.